Market Cap 248.44M
Revenue (ttm) 128.26M
Net Income (ttm) 12.01M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 9.36%
Debt to Equity Ratio 3.12
Volume 75,700
Avg Vol 238,732
Day's Range N/A - N/A
Shares Out 37.03M
Stochastic %K 15%
Beta 0.65
Analysts Strong Sell
Price Target $10.00

Company Profile

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical metho...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: (952) 368-4300
Address:
3515 Lyman Boulevard, Chaska, United States
Jodye_Stojakovic
Jodye_Stojakovic Apr. 21 at 11:26 AM
0 · Reply
itzroly
itzroly Apr. 10 at 9:10 AM
$LFCR lower in shorted this yesterday let’s get that bag Already looking very good
0 · Reply
Charlendwards
Charlendwards Apr. 7 at 1:52 PM
$LFCR The last day of discounts is behind us – the worst is behind us. 📉 Prices are stabilizing today or tomorrow and are poised to rise. The window of opportunity is narrow — act now, or watch from the sidelines as the next rally takes off without you. 🚀 🔋 Nuvve stands out as a compelling investment in these conditions — a first mover in the vehicle-to-grid (V2G) space, backed by key strategic partnerships 🤝, a scalable model 📈, and positioned right at the intersection of energy and mobility. This isn’t just potential — it’s momentum waiting to be capitalized on. ⏳ Get in before the rest of the market catches up.
0 · Reply
Fib7867
Fib7867 Apr. 5 at 6:52 PM
#myLFCRanalysis $LFCR
0 · Reply
theflynews
theflynews Apr. 3 at 11:38 PM
Closing Bell Movers: Futures continues to slip ahead of key jobs data - $LFCR - https://thefly.com/permalinks/entry.php/LFCRid4100146?17437
0 · Reply
d_risk
d_risk Apr. 3 at 8:38 PM
$LFCR - Lifecore Biomedical Inc. Common Stock - 10Q - Updated Risk Factors New risk: U.S. tariffs could raise costs and hurt competitiveness, with retaliatory tariffs potentially impacting international demand. No other substantial changes. #Tariffs #MarketRisks #Competitiveness #InternationalDemand #CostImpact 🟢 Added 🟠 Removed https://d-risk.ai/LFCR/10-Q/2025-04-03
0 · Reply
DonCorleone77
DonCorleone77 Apr. 3 at 8:19 PM
$LFCR Lifecore backs FY25 revenue view $126.5M-$130M, consensus $128.44M Backs FY25 adjusted EBITDA view $19M-$21M. The company said, "For the full fiscal year 2025, the company is reiterating its financial guidance and expects revenue to be approximately $126.5 to $130 million and Adjusted EBITDA to be in the range of $19 to $21 million."
0 · Reply
DonCorleone77
DonCorleone77 Apr. 3 at 8:18 PM
$LFCR Lifecore reports Q3 EPS (47c), consensus (15c) Reports Q3 revenue $35.15M, consensus $33.23M. "During the third quarter, Lifecore continued to aggressively and successfully execute our stated plan for the year, with noteworthy accomplishments across multiple areas of the business. During the third quarter, our team signed multiple new agreements with both new and existing customers. Our revenues for the period were strong and on target with our guidance for the year. Furthermore, our cash balance was strengthened through the sale of our unused filler. Lastly, significant improvements and efficiencies were made throughout the business to enhance our overall operations and improve margins. Today, we believe Lifecore is stronger financially, and our manufacturing pipeline is more developed than at any point in the company's recent history. We are excited to build on this momentum that we believe will position us well to achieve sustainable profitability in the not too distant future," stated Paul Josephs, president and chief executive officer of Lifecore.
0 · Reply
Stocktwits
Stocktwits Apr. 3 at 6:10 PM
Today’s after hours earnings: $GES, $SLP, $LFCR Catch their earnings calls live right here on Stocktwits!
0 · Reply
Stockinvestor73
Stockinvestor73 Apr. 3 at 5:24 PM
$LFCR not much posting on this board.... wats up?
0 · Reply
Latest News on LFCR
Lifecore Biomedical: Inflecting Financials Over Next 3 Years

Jun 18, 2025, 3:27 AM EDT - 2 days ago

Lifecore Biomedical: Inflecting Financials Over Next 3 Years


Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings

May 19, 2025, 9:35 AM EDT - 4 weeks ago

Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings

BUR CLBT KKR PAR


Laughing Water Capital Top 5 Investments (Q1 2025)

Apr 24, 2025, 11:30 AM EDT - 2 months ago

Laughing Water Capital Top 5 Investments (Q1 2025)

ARR NN PAR PLYA


Lifecore Biomedical Announces Special Stockholder Meeting

Jan 17, 2025, 5:24 PM EST - 5 months ago

Lifecore Biomedical Announces Special Stockholder Meeting


Lifecore Biomedical: An Interesting CDMO Pure Play

Dec 1, 2024, 10:40 AM EST - 7 months ago

Lifecore Biomedical: An Interesting CDMO Pure Play


Lifecore Biomedical Hosts Virtual Investor Day

Nov 21, 2024, 4:17 PM EST - 7 months ago

Lifecore Biomedical Hosts Virtual Investor Day


Jodye_Stojakovic
Jodye_Stojakovic Apr. 21 at 11:26 AM
0 · Reply
itzroly
itzroly Apr. 10 at 9:10 AM
$LFCR lower in shorted this yesterday let’s get that bag Already looking very good
0 · Reply
Charlendwards
Charlendwards Apr. 7 at 1:52 PM
$LFCR The last day of discounts is behind us – the worst is behind us. 📉 Prices are stabilizing today or tomorrow and are poised to rise. The window of opportunity is narrow — act now, or watch from the sidelines as the next rally takes off without you. 🚀 🔋 Nuvve stands out as a compelling investment in these conditions — a first mover in the vehicle-to-grid (V2G) space, backed by key strategic partnerships 🤝, a scalable model 📈, and positioned right at the intersection of energy and mobility. This isn’t just potential — it’s momentum waiting to be capitalized on. ⏳ Get in before the rest of the market catches up.
0 · Reply
Fib7867
Fib7867 Apr. 5 at 6:52 PM
#myLFCRanalysis $LFCR
0 · Reply
theflynews
theflynews Apr. 3 at 11:38 PM
Closing Bell Movers: Futures continues to slip ahead of key jobs data - $LFCR - https://thefly.com/permalinks/entry.php/LFCRid4100146?17437
0 · Reply
d_risk
d_risk Apr. 3 at 8:38 PM
$LFCR - Lifecore Biomedical Inc. Common Stock - 10Q - Updated Risk Factors New risk: U.S. tariffs could raise costs and hurt competitiveness, with retaliatory tariffs potentially impacting international demand. No other substantial changes. #Tariffs #MarketRisks #Competitiveness #InternationalDemand #CostImpact 🟢 Added 🟠 Removed https://d-risk.ai/LFCR/10-Q/2025-04-03
0 · Reply
DonCorleone77
DonCorleone77 Apr. 3 at 8:19 PM
$LFCR Lifecore backs FY25 revenue view $126.5M-$130M, consensus $128.44M Backs FY25 adjusted EBITDA view $19M-$21M. The company said, "For the full fiscal year 2025, the company is reiterating its financial guidance and expects revenue to be approximately $126.5 to $130 million and Adjusted EBITDA to be in the range of $19 to $21 million."
0 · Reply
DonCorleone77
DonCorleone77 Apr. 3 at 8:18 PM
$LFCR Lifecore reports Q3 EPS (47c), consensus (15c) Reports Q3 revenue $35.15M, consensus $33.23M. "During the third quarter, Lifecore continued to aggressively and successfully execute our stated plan for the year, with noteworthy accomplishments across multiple areas of the business. During the third quarter, our team signed multiple new agreements with both new and existing customers. Our revenues for the period were strong and on target with our guidance for the year. Furthermore, our cash balance was strengthened through the sale of our unused filler. Lastly, significant improvements and efficiencies were made throughout the business to enhance our overall operations and improve margins. Today, we believe Lifecore is stronger financially, and our manufacturing pipeline is more developed than at any point in the company's recent history. We are excited to build on this momentum that we believe will position us well to achieve sustainable profitability in the not too distant future," stated Paul Josephs, president and chief executive officer of Lifecore.
0 · Reply
Stocktwits
Stocktwits Apr. 3 at 6:10 PM
Today’s after hours earnings: $GES, $SLP, $LFCR Catch their earnings calls live right here on Stocktwits!
0 · Reply
Stockinvestor73
Stockinvestor73 Apr. 3 at 5:24 PM
$LFCR not much posting on this board.... wats up?
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 3 at 12:38 PM
Top Earnings Th 4/3 Aft: $GES $LFCR $SLP $XOM . Top Earnings Fri 4/4 Pre: $AMS
0 · Reply
Stocktwits
Stocktwits Apr. 2 at 6:37 PM
Today’s after-hours earnings: $GES, $SLP, $LFCR Catch their earnings calls live right here on Stocktwits!
0 · Reply
Lowlow1
Lowlow1 Apr. 1 at 3:18 PM
$LFCR AGMH very good price to jump in at 0.042 has to get to a dollar soon if I post again mybad ...,,,,
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 28 at 7:07 AM
$LFCR Interesting CDMO play. Digging their HA manufacturing and strategic pivot. Watching for Q2 guidance confirmation. clear overview of current strategy: https://beyondspx.com/article/lifecore-biomedical-lfcr-a-diversified-cdmo-powering-the-next-wave-of-pharmaceutical-innovations
0 · Reply
DarkAndyStocktwits
DarkAndyStocktwits Jan. 30 at 1:29 PM
$LFCR test low 5s I will enter
0 · Reply
DarkAndyStocktwits
DarkAndyStocktwits Jan. 24 at 1:28 PM
$LFCR looking to start a position in the low 5s👀👀
0 · Reply
DarkAndyStocktwits
DarkAndyStocktwits Jan. 9 at 2:36 AM
$LFCR if the ceo is adding at 5.70s I actually don’t mind opening a long term position here at that price.
0 · Reply
Dieseld28
Dieseld28 Jan. 9 at 12:53 AM
$LFCR $UBX insiders owns Forum 4
1 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jan. 8 at 11:15 PM
$LFCR CEO purchased 17,000 shares at $5.74 for a total of $97,580. Josephs Paul now owns 559,717 shares. https://ceo-buys.com
0 · Reply